HQH (abrdn Healthcare Investors)
Insider Trading Activity
Every open-market purchase and sale reported by HQH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | Chris LaVictoire Mahai | Director | Buy | — | — |
| 2024-07-18 | Rose DiMartino | Director | Buy | — | — |
| 2024-04-12 | Kathleen Goetz | Director | Buy | — | — |
| 2024-01-09 | Alan R Goodson | Vice President | Buy | — | — |
| 2024-01-04 | Todd Reit | Director | Buy | — | — |
| 2024-01-02 | Bill Maher | Director | Buy | — | — |
| 2023-09-25 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2023-09-20 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2022-03-24 | Kathleen Goetz | Director | Buy | — | — |
| 2022-01-27 | Kathleen Goetz | Director | Buy | — | — |
| 2020-10-26 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2020-10-21 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2020-09-23 | Jeffrey Allen Bailey | Director | Buy | — | — |
| 2020-05-22 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2020-03-17 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-12-26 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-10-25 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-10-17 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-01-29 | Thomas M Kent | Director | Buy | — | — |
| 2016-01-07 | Timothy L Gasperoni | — | Buy | — | — |
| 2015-06-29 | LUCINDA H STEBBINS | Director | Buy | — | — |
| 2014-07-11 | UWE E REINHARDT | Director | X | — | — |
| 2014-07-01 | DANIEL R OMSTEAD | President | X | — | — |
| 2013-06-04 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2012-03-21 | OLEG M POHOTSKY | Director | Buy | — | — |
| 2012-03-12 | MICHAEL W BONNEY | Director | Buy | — | — |
| 2012-03-12 | WILLIAM S REARDON | Director | Buy | — | — |
| 2011-08-08 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2009-09-11 | LUCINDA H STEBBINS | Director | Buy | — | — |
| 2009-08-06 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2008-12-01 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2008-10-14 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2007-11-26 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2007-10-04 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2007-08-22 | LUCINDA H STEBBINS | Director | Buy | — | — |
| 2007-08-06 | DANIEL R OMSTEAD | President | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President | 178,268 | — |
| — | Director | 6,660 | — |
| — | Director | 3,049 | — |
| — | Director | 1,100 | — |
| — | Director | 1,079 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
| — | — | 862 | — |
| — | Director | 665 | — |
| — | Director | 661 | — |
| — | Director | 501 | — |
| — | Director | 490 | — |
| — | Director | 204 | — |
| — | Vice President | 170 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HQH quote page; the site-wide leaderboard is on the insider transactions hub.